182 related articles for article (PubMed ID: 21610145)
1. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair.
Yin JY; Shen J; Dong ZZ; Huang Q; Zhong MZ; Feng DY; Zhou HH; Zhang JT; Liu ZQ
Clin Cancer Res; 2011 Jul; 17(13):4600-9. PubMed ID: 21610145
[TBL] [Abstract][Full Text] [Related]
2. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation.
Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
[TBL] [Abstract][Full Text] [Related]
3. MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway.
Fang C; Chen YX; Wu NY; Yin JY; Li XP; Huang HS; Zhang W; Zhou HH; Liu ZQ
Sci Rep; 2017 Jan; 7():40384. PubMed ID: 28074905
[TBL] [Abstract][Full Text] [Related]
4. The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair.
Chen J; Liu JY; Dong ZZ; Zou T; Wang Z; Shen Y; Zhuo W; Li XP; Xiao D; Liu HT; Chen X; Zhou HH; Liu ZQ; Zhang JT; Yin JY
Biochem Pharmacol; 2021 Aug; 190():114616. PubMed ID: 34022189
[TBL] [Abstract][Full Text] [Related]
5. Role of eIF3a in regulating cisplatin sensitivity and in translational control of nucleotide excision repair of nasopharyngeal carcinoma.
Liu RY; Dong Z; Liu J; Yin JY; Zhou L; Wu X; Yang Y; Mo W; Huang W; Khoo SK; Chen J; Petillo D; Teh BT; Qian CN; Zhang JT
Oncogene; 2011 Dec; 30(48):4814-23. PubMed ID: 21625209
[TBL] [Abstract][Full Text] [Related]
6. The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients.
Xu X; Han L; Yang H; Duan L; Zhou B; Zhao Y; Qu J; Ma R; Zhou H; Liu Z
Lung Cancer; 2013 Jan; 79(1):65-72. PubMed ID: 23127338
[TBL] [Abstract][Full Text] [Related]
7. Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer.
Long J; Zhu JY; Liu YB; Fu K; Tian Y; Li PY; Yang WQ; Yang SY; Yin JY; Yin G; Zhang Y
Gynecol Oncol; 2018 May; 149(2):341-349. PubMed ID: 29572031
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
9. eIF3a R803K mutation mediates chemotherapy resistance by inducing cellular senescence in small cell lung cancer.
Chen YX; Wang CJ; Xiao DS; He BM; Li M; Yi XP; Zhang W; Yin JY; Liu ZQ
Pharmacol Res; 2021 Dec; 174():105934. PubMed ID: 34648968
[TBL] [Abstract][Full Text] [Related]
10. Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients.
Yin JY; Meng XG; Qian CY; Li XP; Chen J; Zheng Y; Liu R; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2015 Mar; 36(3):375-84. PubMed ID: 25732572
[TBL] [Abstract][Full Text] [Related]
11. Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway.
Mei Y; Liu YB; Hu DL; Zhou HH
Int J Biol Sci; 2018; 14(13):1859-1872. PubMed ID: 30443189
[TBL] [Abstract][Full Text] [Related]
12. Effect of docetaxel on expression of eIF3a in human lung cancer A549 cell line.
Gong Z; Xu X; Hou R; Guo Y; Sheng F; Ouyang D; Zhou H; Liu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):771-6. PubMed ID: 20818067
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of eIF3a attenuated cell growth in K1 human thyroid cancer cells.
Zheng X; Wang S; Hong S; Liu J; Jiang C
Genes Genomics; 2021 Apr; 43(4):379-388. PubMed ID: 33595813
[TBL] [Abstract][Full Text] [Related]
14. [eIF3a gene polymorphism and chemo-sensitivity to platinum-based drugs in ovarian cancer].
Zhang C; Zhang S; Liu Y; Tian Y; Li X; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 40(6):617-22. PubMed ID: 26164510
[TBL] [Abstract][Full Text] [Related]
15. eIF3a Regulation of NHEJ Repair Protein Synthesis and Cellular Response to Ionizing Radiation.
Tumia R; Wang CJ; Dong T; Ma S; Beebe J; Chen J; Dong Z; Liu JY; Zhang JT
Front Cell Dev Biol; 2020; 8():753. PubMed ID: 32974334
[TBL] [Abstract][Full Text] [Related]
16. Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat.
To KK; Tong WS; Fu LW
Lung Cancer; 2017 Jan; 103():58-65. PubMed ID: 28024697
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA screening from EIF3a in lung cancer.
Huang MS; Yuan FQ; Gao Y; Liu JY; Chen YX; Wang CJ; He BM; Zhou HH; Liu ZQ
Cancer Med; 2019 Aug; 8(9):4159-4168. PubMed ID: 31197975
[TBL] [Abstract][Full Text] [Related]
18. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic Translation Initiation Factor 3a (eIF3a) Promotes Cell Proliferation and Motility in Pancreatic Cancer.
Wang SQ; Liu Y; Yao MY; Jin J
J Korean Med Sci; 2016 Oct; 31(10):1586-94. PubMed ID: 27550487
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a.
Chen T; Sun L; Yao B; Wang L; Wang Y; Niu Y; Liu R; Mo H; Liu Z; Tu K; Liu Q
Oncol Rep; 2020 Nov; 44(5):2067-2079. PubMed ID: 33000235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]